Signalling profile and antitumour activity of the novel Hsp90 inhibitor NVP-AUY922 in multiple myeloma. (Q39982294)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18480838%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

title

Signalling profile and antitumour activity of the novel Hsp90 inhibitor NVP-AUY922 in multiple myeloma (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18480838%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18480838%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

M Kortüm

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18480838%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

author name string

T Stühmer

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18480838%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

A Zöllinger

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18480838%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

D Siegmund

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18480838%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

M Chatterjee

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18480838%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

E Grella

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18480838%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

S Knop

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18480838%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

C Unzicker

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18480838%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

M R Jensen

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18480838%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

C Quadt

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18480838%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

P Chène

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18480838%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

J Schoepfer

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18480838%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

C García-Echeverría

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18480838%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

H Einsele

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18480838%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

R C Bargou

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18480838%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

language of work or name

1 reference

15 May 2008

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18480838%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18480838%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

volume

22

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18480838%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

issue

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18480838%20AND%20SRC:MED&resulttype=core&format=json

7 January 2020

page(s)

1604-1612

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18480838%20AND%20SRC:MED&resulttype=core&format=json

Early genetic events provide the basis for a clinical classification of multiple myeloma.

7 January 2020

cites work

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.111

7 January 2021

https://api.crossref.org/works/10.1038%2FLEU.2008.111

1 reference

7 January 2021

HSP90 and the chaperoning of cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.111

7 January 2021

Heat shock protein 90: a unique chemotherapeutic target

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.111

7 January 2021

"The stress of dying": the role of heat shock proteins in the regulation of apoptosis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.111

7 January 2021

Benzoquinone ansamycin heat shock protein 90 inhibitors modulate multiple functions required for tumor angiogenesis

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.111

7 January 2021

Antimyeloma activity of heat shock protein-90 inhibition.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.111

7 January 2021

STAT3 and MAPK signaling maintain overexpression of heat shock proteins 90alpha and beta in multiple myeloma cells, which critically contribute to tumor-cell survival

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.111

7 January 2021

Development of 17-allylamino-17-demethoxygeldanamycin hydroquinone hydrochloride (IPI-504), an anti-cancer agent directed against Hsp90.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.111

7 January 2021

Analysis of expression of heat shock protein-90 (HSP90) and the effects of HSP90 inhibitor (17-AAG) in multiple myeloma.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.111

7 January 2021

Inhibition of heat shock protein HSP90-pp60v-src heteroprotein complex formation by benzoquinone ansamycins: essential role for stress proteins in oncogenic transformation

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.111

7 January 2021

Plasma pharmacokinetics and tissue distribution of 17-(allylamino)-17-demethoxygeldanamycin (NSC 330507) in CD2F1 mice1.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.111

7 January 2021

Preclinical toxicity of a geldanamycin analog, 17-(dimethylaminoethylamino)-17-demethoxygeldanamycin (17-DMAG), in rats and dogs: potential clinical relevance

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.111

7 January 2021

Heat shock protein 90.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.111

7 January 2021

4,5-diarylisoxazole Hsp90 chaperone inhibitors: potential therapeutic agents for the treatment of cancer

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.111

7 January 2021

Pharmacologic activation of p53-dependent and p53-independent apoptotic pathways in Hodgkin/Reed-Sternberg cells

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.111

7 January 2021

Death receptor-induced signaling pathways are differentially regulated by gamma interferon upstream of caspase 8 processing

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.111

7 January 2021

Tumor selectivity of Hsp90 inhibitors: the explanation remains elusive

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.111

7 January 2021

Involvement of heat-shock protein 90 in the interleukin-6-mediated signaling pathway through STAT3.

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.111

7 January 2021

The heat shock protein 90-CDC37 chaperone complex is required for signaling by types I and II interferons

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.111

7 January 2021

The role of the bone microenvironment in the pathophysiology and therapeutic management of multiple myeloma: interplay of growth factors, their receptors and stromal interactions

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.111

7 January 2021

Proteasome inhibitor therapy in multiple myeloma

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.111

7 January 2021

Inhibitors of the HSP90 molecular chaperone: current status

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.111

7 January 2021

In vitro Biological Characterization of a Novel, Synthetic Diaryl Pyrazole Resorcinol Class of Heat Shock Protein 90 Inhibitors

1 reference

https://api.crossref.org/works/10.1038%2FLEU.2008.111

7 January 2021